BDR Pharmaceuticals Internationals

Mumbai, India Founded: 2003 • Age: 23 yrs Soonicorn
APIs and finished products are developed and manufactured.

About BDR Pharmaceuticals Internationals

BDR Pharmaceuticals Internationals is a Healthcare company based in Mumbai (India) founded in 2003 by Dharmesh Shah. APIs and finished products are developed and manufactured. BDR Pharmaceuticals Internationals has raised $88.16 million across 1 funding round from investors including BKT Tires, State Bank of India and Multiples Alternate Asset Management. The company has 1,864 employees. BDR Pharmaceuticals Internationals was last valued at $950.33 million in January 2022. BDR Pharmaceuticals Internationals offers products and services including API, Formulations, and Pellets. Its focus areas include Biopharma Outsourcing, CDMO and Small Molecules & Peptides. Its legal entity is BDR Pharmaceuticals Internationals Pvt. Ltd. Its competitors include Indoco Remedies, Concord Biotech and Aurobindo Pharma.

Company details

BDR Pharmaceuticals Internationals was established in 2003 in Mumbai, India. Active pharmaceutical ingredients are developed and produced, alongside finished formulations. New drug delivery systems and generic versions are created for therapeutic segments including oncology, critical care, gynecology, respiratory conditions, antidiabetics, neurology, and additional categories. Manufacturing sites are certified under WHO-GMP standards.

Recognitions & Rankings of BDR Pharmaceuticals Internationals

India's Most Valuable Companies 2024 edition · Source: Hurun India
Rank#419
Valuation
₹11,950 Cr
2023 #374 2022 #409
  • Headquarters Mumbai, India
  • Employees 1,864
  • Founders Dharmesh Shah
  • Stage Soonicorn
  • Sectors
    Healthcare
  • Website category Health · Biotechnology and Pharmaceuticals
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website bdrpharma.com
  • Social LinkedIn X Facebook
  • Legal Name Bdr Pharmaceuticals Internationals Pvt. Ltd.
Key Metrics
  • Annual Revenue
    $134.65 M (USD)
    8
    as on Mar 31, 2024
  • Net Profit
    $28.89 M (USD)
    16
    as on Mar 31, 2024
  • EBITDA
    $43.81 M (USD)
    16
    as on Mar 31, 2024
  • Total Equity Funding
    $88.16M (USD)

    in 1 rounds

  • Latest Funding Round
    $88.16M (USD), Private Equity Round

    Jan 2022

  • Investors
    BKT Tires

    & 9 more

  • Employee Count
    1,864

Products & Services of BDR Pharmaceuticals Internationals

BDR Pharmaceuticals Internationals offers a comprehensive portfolio of products and services, including API, Formulations, and Pellets.

API
Active Pharmaceutical Ingredients

Manufactures niche APIs with advanced facilities for quality compliance.

Formulations
Generic Medications

Develops and markets various dosage forms for affordable healthcare.

Pellets
Drug Delivery Systems

Creates sustained-release pellets using innovative technologies.

Funding Insights of BDR Pharmaceuticals Internationals

BDR Pharmaceuticals Internationals has successfully raised a total of $88.16M through 1 strategic funding round. The most recent funding activity was a Private Equity Round of $88.16 million completed in January 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $88.16M
  • Total Rounds 1
  • Last Round Private Equity Round β€” $88.16M
  • First Round $88.16M

    (Jan 2022)

  • Investors Count 10

All 1 funding rounds of BDR Pharmaceuticals Internationals with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2022$88.16MPrivate Equity Round$950.33MMultiples Alternate Asset Management
Valuation history
DateValuationStage
Jan 2022$950.33Mβ€’β€’β€’β€’β€’β€’β€’β€’

Last known valuation $950.33M (Jan 2022). 10 investors in total: 7 institutional and 3 angel.

Investors in BDR Pharmaceuticals Internationals

BDR Pharmaceuticals Internationals has secured backing from 10 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include BKT Tires, State Bank of India and Multiples Alternate Asset Management.

All
Venture Fund
Institutional
Angel
InvestorDescriptionFounded YearDomainLocation
Investment partnerships, entrepreneur support, and profit-focused services in finance.
2009multiplesequity.comMumbai, India
Schools and pre-schools are established in India and abroad.
2000kamaholdings.comGurugram, India
Venture capital firm focused on early-stage companies
Faridabad, India
HCL Capital is engaged in impact-driven investments across sectors.
hcl-capital.comHong Kong, Hong Kong
Off-highway tires for commercial vehicles are manufactured.
1987bkt-tires.comMumbai, India
State Bank of India is engaged in providing banking and financial services.
1955onlinesbi.sbiMumbai, India

Nishant Agarwal

Angel investor, tech entrepreneur, ex-CTO of Cred, focused on fintech
unknown_069f9fb1e23e46648

Mallika Srinivasan

unknown_92d65d4826544eadb

Nishant Agarwal

Angel investor, tech entrepreneur, ex-CTO of Urban Company, active in startups
unknown_2aeba78d1ae740efa
Premium access

Investor details for BDR Pharmaceuticals Internationals

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of BDR Pharmaceuticals Internationals

The boards of the 5 registered companies of BDR Pharmaceuticals Internationals currently have 16 directors; the longest-serving is Narendra Bhagwandas Jariwala, appointed in 1994. 20 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Narendra Bhagwandas Jariwala
DIN 01029286
Director01 Feb 199432 yrs 9 moVirdev Intermediates Private Limited
Kaushik Bhagwandas Jariwala
DIN 01029229
Director12 Nov 200026 yrsVirdev Intermediates Private Limited
Sanjay Amritlal Solanki
DIN 01838642
Director12 Nov 200026 yrsVirdev Intermediates Private Limited, Bdr Lifesciences Private Limited
Viralkumar Narendrabhai Jariwala
DIN 01667767
Director12 Nov 200026 yrsVirdev Intermediates Private Limited
Venkata Reddy Puchakayala
DIN 01851974
Managing Director14 Jun 200521 yrs 5 moMagnum Chemi-Gran Private Limited
Ketan Suresh Shah
DIN 03149312
Director05 Jul 201016 yrs 4 moBdr Lifesciences Private Limited
Chenna Reddy Puchakayala
DIN 03198883
Director02 May 201214 yrs 6 moMagnum Chemi-Gran Private Limited
Trushit Pramodray Mehta
DIN 06439479
Director01 Nov 201214 yrsBdr Lifesciences Private Limited
Aravind Manappa Badiger
DIN 06540340
Director15 Dec 201213 yrs 11 moBdr Pharmaceuticals International Private Limited, Magnum Chemi-Gran Private Limited
Raheel Dharmesh Shah
DIN 03582861
Director27 Jul 20188 yrs 3 moVirdev Intermediates Private Limited, Bdr Lifesciences Private Limited, Bdr Pharmaceuticals International Private Limited, Magnum Chemi-Gran Private Limited
Jayesh Shantilal Trivedi
DIN 08980462
Director04 Dec 20205 yrs 11 moBdr Pharmaceuticals International Private Limited
Tejash Vijay Shah
DIN 01862033
Director19 Apr 20215 yrs 7 moBdr Lifesciences Private Limited, Bdr Pharmaceuticals International Private Limited, Magnum Chemi-Gran Private Limited
Rupi Romil Kapadia
DIN 09519200
Designated Partner24 Feb 20224 yrs 8 moBd-Verse Llp
Dheer Dharmesh Shah
DIN 07937075
Designated Partner24 Feb 20224 yrs 8 moBd-Verse Llp, Virdev Intermediates Private Limited, Bdr Lifesciences Private Limited
Manish Gaur
DIN 00340911
Nominee Director12 May 20224 yrs 6 moBdr Pharmaceuticals International Private Limited
Dharmesh Mahendra Shah
DIN 00452961
Director13 May 20224 yrs 6 moBdr Pharmaceuticals International Private Limited

People of BDR Pharmaceuticals Internationals

7 people are tracked at BDR Pharmaceuticals Internationals (4 in leadership, 3 in team); the tracked headcount is 1,864.

NameRoleGroup
Founder & ChairmanLeadership
DirectorLeadership
DirectorLeadership
DirectorLeadership
Darshan Ka Patel
Purchase OfficerTeam
Vijay Patel
Senior ExecutiveTeam
Mohammad Sonu
Senior OfficerTeam
Premium access

Complete people profiles for BDR Pharmaceuticals Internationals

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of BDR Pharmaceuticals Internationals

Figures of Virdev Intermediates Private Limited, the primary company behind BDR Pharmaceuticals Internationals, for FY 2025. Revenue was ₹108 Cr (-3% year on year). Net profit was ₹8.71 Cr (8% margin). EBITDA was ₹16.95 Cr (16% margin). Revenue has grown at a compounded annual rate of -2% over three years and +21% over five years.

  • ₹108 CrRevenue · FY 2025 · -3% YoY
  • ₹8.71 CrNet profit · 8% margin
  • ₹16.95 CrEBITDA · 16% margin
  • ₹5.41 CrPaid-up capital
  • 313Employees (provident fund records)
  • -2%Revenue CAGR, 3 years
  • +21%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Virdev Intermediates Private Limited are on its company page.

Premium access

Detailed financial statements for BDR Pharmaceuticals Internationals

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of BDR Pharmaceuticals Internationals

3 dated milestones of BDR Pharmaceuticals Internationals across 19 years, from founding to its latest funding, stage changes and deals.

  1. Founded BDR Pharmaceuticals Internationals is founded.
  2. Funding First funding round of $88.2M.
  3. Milestone Reaches Soonicorn status.

Competitors of BDR Pharmaceuticals Internationals

BDR Pharmaceuticals Internationals has 3 listed competitors in our database. They include Indoco Remedies, Concord Biotech and Aurobindo Pharma.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
indoco.com1947Mumbai, India6,291
APIs manufacturing and formulation services are provided in therapeutic segments.
concordbiotech.com2000Ahmedabad, India1,598
APIs and enzymes are manufactured through fermentation by the CDMO.
aurobindo.com1986Hyderabad, India1,010
Generic biocatalytic solutions are provided for pharmaceutical applications.
Premium access

Detailed competitors of BDR Pharmaceuticals Internationals

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of BDR Pharmaceuticals Internationals

The website of BDR Pharmaceuticals Internationals (bdrpharma.com) receives about 3.3K visits a month and ranks #4,388,942 among all websites worldwide, #5,343 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    3.3K

    ▼ 18.6% vs previous month

  • Unique visitors
    1.7K

    per month

  • Global rank
    #4,388,942

    among all websites

  • Category rank
    #5,343

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with BDR Pharmaceuticals Internationals. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
samilabs.com
100%
View details
pharmexcil.com
pharmexcil.com
94%
#794,041–
microcellulose.com
93%
#7,291,109View details

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as BDR Pharmaceuticals Internationals (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of integrated contract research development and manufacturing services
2007Bengaluru, Karnataka, IndiaUSD 35.74 MUSD 226.38 M2,062
Pharmaceutical and biotechnology company
2005Hyderabad, Telangana, IndiaUSD 229.73 MUSD 726.15 M548
India's leading healthcare products distribution platform
2018Mumbai, Maharashtra, IndiaUSD 59.67 MUSD 702.49 M557
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Bdr Pharmaceuticals Internationals

Premium access

Complete news archive for BDR Pharmaceuticals Internationals

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about BDR Pharmaceuticals Internationals

BDR Pharmaceuticals Internationals was founded in 2003 and raised its 1st funding round 19 years after it was founded.

BDR Pharmaceuticals Internationals is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

BDR Pharmaceuticals Internationals is a funded company, having raised a total of $88.16M across 1 funding round to date. The company's 1st funding round was a Private Equity Round of $88.16M, raised on Jan 2022.

BDR Pharmaceuticals Internationals has 1,864 employees.

Annual revenue of BDR Pharmaceuticals Internationals is $134.65M as on Mar 31, 2024.

BDR Pharmaceuticals Internationals was established in 2003 in Mumbai, India. Active pharmaceutical ingredients are developed and produced, alongside finished formulations. New drug delivery systems and generic versions are created for therapeutic segments including oncology, critical care, gynecology, respiratory conditions, antidiabetics, neurology, and additional categories. Manufacturing sites are certified under WHO-GMP standards.

BDR Pharmaceuticals Internationals's top competitors include Concord Biotech, Indoco Remedies and Aurobindo Pharma.

BDR Pharmaceuticals Internationals offers API, Formulations, and Pellets.

BDR Pharmaceuticals Internationals has 10 investors. Key investors include BKT Tires, State Bank of India, Multiples Alternate Asset Management, Kama Holdings, and Nishant Agarwal.

The valuation of BDR Pharmaceuticals Internationals is $950.33M as of Jan 2022.

BDR Pharmaceuticals Internationals is associated with 5 legal entities: Bd-Verse Llp, Virdev Intermediates Private Limited, Bdr Lifesciences Private Limited and others.

The legal entities of BDR Pharmaceuticals Internationals currently have 18 directors, including Rupi Romil Kapadia, Dheer Dharmesh Shah, Kaushik Bhagwandas Jariwala and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available